Spots Global Cancer Trial Database for children and adolescents
Every month we try and update this database with for children and adolescents cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Neurocognitive Function After Proton Therapy in Children and Adolescents | NCT04066465 | Primary Brain T... | 8 Years - 18 Years | Technische Universität Dresden | ||
A Study to Determine Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib In Children and Adolescent Subjects | NCT01677741 | Neoplasms, Brai... | Dabrafenib | 12 Months - 17 Years | Novartis | |
Acceptance and Commitment Therapy for Neuro-Oncology Wellbeing | NCT04722237 | Brain Tumors Quality of Life Brain Tumor, Pe... | Acceptance and ... | 11 Years - 24 Years | Nottingham University Hospitals NHS Trust | |
Integrative Neuromuscular Training in Adolescents and Children Treated for Cancer | NCT04706676 | Pediatric Cance... Leukemia Neoplasms Lymphoma Solid Tumor CNS Tumor | Integrative neu... Active control ... motivational co... | 6 Years - 18 Years | Rigshospitalet, Denmark | |
A Study to Determine Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib In Children and Adolescent Subjects | NCT01677741 | Neoplasms, Brai... | Dabrafenib | 12 Months - 17 Years | Novartis | |
Correlation of Polymorphisms of Lipoprotein Lipase (LpL) and Apolipoprotein E (Apo E) With Lipid Profile of Children With Acute Lymphoblastic Eukaemia During Therapy With L - Asparaginase. | NCT04364451 | Acute Lymphobla... | Correlation of ... | - 16 Years | Aristotle University Of Thessaloniki | |
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia | NCT01949129 | Acute Lymphobla... | VP16 TBI Thiotepa Treosulfan Fludarabine Busulfan ATG Thymoglobul... Cyclophosphamid... Grafalon | 1 Month - 18 Years | St. Anna Kinderkrebsforschung | |
The Children and Adolescents Nasopharyngeal Carcinoma Survivor Study | NCT03637634 | NPC Patients | - 21 Years | Sun Yat-sen University | ||
HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors | NCT01509300 | Acute Leukemia Myelodysplastic... Solid Tumors | anti-thymocyte ... filgrastim Total body irra... Fludarabine cyclophosphamid... Tacrolimus Mycophenolate m... Rituximab | - 21 Years | Asan Medical Center | |
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia | NCT01949129 | Acute Lymphobla... | VP16 TBI Thiotepa Treosulfan Fludarabine Busulfan ATG Thymoglobul... Cyclophosphamid... Grafalon | 1 Month - 18 Years | St. Anna Kinderkrebsforschung | |
Acceptance and Commitment Therapy for Neuro-Oncology Wellbeing | NCT04722237 | Brain Tumors Quality of Life Brain Tumor, Pe... | Acceptance and ... | 11 Years - 24 Years | Nottingham University Hospitals NHS Trust |